Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,473 | Dovepress* | 11,466+ | 1,171 | 12,637 | |
| PubMed Central* | 3,007 | 526 | 3,533 | ||
| Totals | 14,473 | 1,697 | 16,170 | ||
| *Since 5 October 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar